About Business

Business Summary

Navi Mumbai-based listed diagnostic company providing pathology investigations, Aarogyam preventive profiles, Jaanch targeted packages and collection services for consumer and institutional customers.

Business Description

Patients can access named investigations or choose a published health profile, while healthcare organisations can enquire about diagnostic processing arrangements. Collection availability, preparation and reporting depend on the particular test and location.

Detailed Business Description

Thyrocare Technologies Limited connects patients and healthcare partners with a nationwide pathology-testing network based in Navi Mumbai.

At a Glance

Explore tests and packages Find a collection centre

Executive Overview

Thyrocare brings together specimen collection, laboratory processing and report delivery. Its consumer-facing service is one part of a wider diagnostic operation that also works with healthcare and institutional partners. This distinction matters: the location at which a person supplies a sample need not be the processing laboratory, and a package sold online is a defined group of investigations rather than a medical consultation.

Company Milestones

1. 1995–1996 — Business beginnings

   The investor FAQ dates the founding to 1995; the FY2025–26 annual report dates the start of thyroid testing to 1996. Both precede legal incorporation.

   Company history

2. 2000 — Company incorporated

   Thyrocare Technologies Limited was incorporated in 2000, establishing the company identity behind the diagnostic business.

   Incorporation history

3. 2016 — IPO and stock-exchange listing

   The initial public offering took place in April, followed by share listing on 9 May 2016. The investor FAQ identifies the NSE symbol THYROCARE and BSE code 539871.

   IPO and listing record

4. 2021 — Joined the API Holdings group

   Thyrocare’s official company account records its entry into the API Holdings family in 2021 and describes the connection with the group’s digital-health ecosystem, including PharmEasy.

   Official company account

5. May 2026 — Specialty-testing expansion reported

   In its 7 May release, Thyrocare reported expanding advanced allergy testing on the Phadia platform. This is a dated service-development disclosure, separate from the current local availability of an individual investigation.

   Company release filed with NSE

The official board page identifies Rahul Guha as Managing Director and Chief Executive Officer. The milestones above describe the organisation’s development; its present services and laboratory scope are explained below.

Collection, Processing and Digital Reports

The company describes a tiered processing network with central, zonal, regional and hybrid laboratories, alongside a laboratory in Tanzania. The Indian consumer website should be used to check local collection arrangements; international presence does not establish that an Indian booking service covers another country.

Thyrocare describes barcoded specimens, temperature-controlled logistics, automated analysers and pathologist review as parts of its workflow. Each stage has a different purpose: identification follows the specimen, transport addresses handling conditions, and laboratory analysis produces measurements for the report. These controls address different stages of the specimen pathway.

A practical distinction in the company’s reporting claims is the starting point of the clock. Its published analytical-turnaround measure begins after a specimen reaches the laboratory. It should not be read as a promise of the same number of hours from a home visit to the complete report. Test-specific processing and collection logistics remain relevant.

Accreditation with a Defined Laboratory Scope

The live NABL directory reviewed on 24 October 2026 lists Thyrocare’s D37/1, TTC MIDC, Turbhe laboratory under CAB M-1048, certificate MC-2407, with validity from 27 September 2025 to 26 September 2029. Its entry includes clinical biochemistry, clinical pathology, cytopathology, flow cytometry, haematology, histopathology, microbiology and infectious-disease serology, and molecular testing. The detailed certificate scope determines which examinations and methods are covered.

Accreditation applies to the identified laboratory and its documented examinations, methods and conditions. A collection point is not automatically a separately accredited processing laboratory. For a specialist investigation, the processing site and relevant scope are the useful details to establish.

Laboratory Infrastructure and Reach

The FY2025–26 annual report records 41 laboratories, including one in Tanzania, and more than 10,800 active franchisees. These are dated company disclosures: franchise access points and processing laboratories serve different functions.

Technology and Practical Reporting Features

The FY2025–26 report describes Helix and Roche Cobas p 512 integration for transport visibility and sample routing. Its ThyroNXT partner platform includes processing-status visibility and interim reports for completed parameters. These are company-described capabilities, not guarantees for every booking.

Customer Groups and Typical Uses

Individuals can approach Thyrocare for a named investigation or a selected preventive profile. Clinicians and healthcare providers use laboratory measurements as part of patient assessment and follow-up. Employers, insurers and health-technology platforms have a different need: organised access to testing across a defined group or operating area. The appropriate enquiry therefore depends on whether the requirement concerns one patient, a workplace programme or a diagnostic partnership.

Booking and Customer Support

The official website and app are the main consumer booking routes, supported by the published phone and WhatsApp channels. Booking guidance distinguishes an initial selection from a confirmed collection appointment. For tests requiring a prescription, the platform says the requirement is indicated during booking.

For an existing booking, use the confirmation details and customer-support routes rather than a shareholder contact. Test selection and interpretation should be discussed with a qualified clinician when needed. Laboratory testing supplies clinical information; neither a broad package nor an individual result replaces an assessment of symptoms and medical history.

Registered Office and Enquiries

The published registered-office address is D-37/1, TTC Industrial Area, MIDC, Turbhe, Navi Mumbai 400703, Maharashtra, India. The FY2025–26 corporate disclosure separately identifies D-37/3 in the same industrial area as the corporate office. Customers arranging a collection visit should use the selected centre’s details, not assume either office accepts walk-ins.

The main consumer website publishes +91 86578 58858, +91 22 6712 3400, WhatsApp +91 98706 66333 and [email protected].

Booking Channels and Service Conditions

Thyrocare’s published terms distinguish its laboratory services from authorised third-party collection centres and certain tests facilitated through partner laboratories. Confirm the processing provider when booking a specialist investigation. A familiar collection brand does not by itself identify the laboratory performing every test.

The cancellation policy distinguishes orders before collection, samples collected but not processed, and completed testing. Refund eligibility and deductions depend on that stage and the reason. Check the current terms for the booked service rather than assume an unconditional refund.

Frequently Asked Questions

How do Aarogyam and Jaanch differ?

Aarogyam groups tests for broad preventive assessment. Jaanch profiles focus on particular health concerns. Their names do not make them interchangeable: compare the included parameters and the purpose of the investigation with your clinician.

Does a laboratory turnaround figure start at home collection?

Not necessarily. Thyrocare’s corporate analytical-time measure starts when the sample reaches the laboratory. Collection, transport, specialised processing and final report release are separate stages. Ask for the expected timeline for the specific booking.

Can every profile use the same specimen and preparation?

No. The Aarogyam X page reviewed specifies blood and urine with fasting, while the Jaanch Men’s Skin Care page lists a blood specimen without fasting. These are examples, not universal instructions; follow the current directions for the exact tests ordered.

Is a collection centre the laboratory that analyses my sample?

Not automatically. The official locator identifies customer-facing collection points, while processing takes place at the assigned laboratory. Confirm the collection address and the processing laboratory when that distinction matters for your enquiry.

Can I book for family members together?

The official FAQ allows multiple beneficiaries in one booking. Each person still needs the correct individual details and selected tests; confirm preparation and collection arrangements for each beneficiary.

Should patients use the investor-relations contact for reports?

No. For bookings and reports, use the customer channels published on Thyrocare’s main website. The separate investor-relations site is intended for shareholder and corporate-disclosure enquiries.

Does Thyrocare perform every test in its own laboratories?

The published terms allow certain investigations to be facilitated through partner laboratories. Ask which laboratory will process the selected test and check the relevant scope rather than infer it from the collection centre.

Does cancellation always mean a full refund?

No. The official policy distinguishes the stage reached in collection and processing, the reason for cancellation and applicable deductions. Refer to the current policy for the booked service.

Information Sources

Company and laboratory model; Customer booking guidance; Aarogyam package example; Company history; NABL laboratory directory; May 2026 specialty-testing disclosure; FY2025–26 annual report — network, technology and service development.

Business representative or reader with a correction? Contact Siachen with this profile URL and a supporting source.

Siachen Business Information & Verification

Independent information checks for this business profile.

These statuses describe Siachen’s information checks, not the business’s quality or reliability. ‘Not Yet Checked’ means Siachen has not yet assessed this item. ‘Not Yet Verified’ means a check was attempted but sufficient evidence was not established. It does not imply that the business lacks credentials or is operating improperly. Public information and Siachen’s research may be incomplete or outdated.

iOfficial Website Supported

iBusiness Contact Supported

iBusiness Email Domain Matched

iBusiness Location Supported — Turbhe registered office

✓Registration / Licence Verified — Turbhe NABL MC-2407 scope only

iOperating History Supported — business beginnings 1995–1996; company sources

–Employee Count Not Yet Verified — current total not established

iLegal / Company Type Public Limited Company

iIncorporation / Registration Status Supported — listed-company disclosures

iIncorporation / Registration Year 2000 — company disclosures

✓Public Listing Status Listed

iStock Exchange / Ticker NSE: THYROCARE; BSE: 539871

iRegistering Representative Name Not provided

iRepresentative Position / Designation Not provided

–Representative Verification Not Yet Verified

Information checks are not a product-quality assessment, endorsement or guarantee of service. The accreditation check concerns the listed Turbhe laboratory and its published scope, not every facility, test or statutory authorisation.

Contact details are publicly supported; calls and email delivery were not tested. Email domain matching does not establish mailbox ownership or representative authority. Operating history and incorporation are separate.

Information last reviewed — 24 October 2026

Siachen Reader Note

Business information naturally evolves over time as organisations introduce new products, services, facilities, technologies, certifications, leadership changes and operational improvements.

This Business Knowledge Profile begins with information submitted by the business owner or representative. Siachen then reviews, verifies where possible, and enhances that information using the company’s official website, where available, and other reliable public sources before publishing the revised profile.

As business information may change after publication, readers are encouraged to visit the company's official website, where available, or contact the business directly to obtain the latest information regarding products, services, pricing, operating hours, admissions, appointments, certifications, contact details, locations and other important updates before making business decisions.

Siachen Business Knowledge Platform periodically reviews Business Knowledge Profiles wherever practical. However, the official website, where available, and authorised representatives of the business remain the most reliable sources of current information.

Photo & Video Media

Corporate Business Video

Products / Services

Individual Pathology Tests

Customers can search the official catalogue for specific investigations rather than select a broad package. Prominent categories include thyroid function, blood glucose, lipids, liver and kidney function, vitamins and fever-related tests. This route is relevant when a clinician requests named investigations or when a defined follow-up test is needed. The exact assay, specimen and preparation should be checked against the current listing.

Aarogyam Preventive Profiles

Aarogyam combines several laboratory measurements into preventive health profiles. Options differ in their contents, not simply in their names or prices. For example, the Aarogyam X with UTSH page reviewed includes blood and urine testing, vitamins, elements and other groups of parameters. A package’s parameter count is not the number of diseases it can diagnose, nor proof that it is appropriate for every person. The live contents and preparation requirements are more useful than a broad “full body” label.

Jaanch Targeted Profiles

Jaanch groups investigations around particular health concerns rather than treating every enquiry as a general wellness check. The published Men’s Skin Care profile, for example, combines blood-count, thyroid, vitamin and selected immunological measurements. Its results provide information for clinical assessment; a profile name alone does not establish the cause of a symptom. The relevant choice depends on the clinical question and the tests actually included.

Home Sample Collection

The consumer platform supports choosing an available collection slot. A phlebotomist collects the specimen for transport to the laboratory; this is not a medical consultation or an emergency response. The official booking guidance makes confirmation dependent on technician availability and reconfirmation. Customers should check serviceability for their postal code, the selected specimen and the appointment rather than infer universal coverage from the national brand.

Collection-Centre Access

The official Labs Near Me directory lists local Thyrocare Aarogyam centres and their contact details. It provides an alternative starting point for people seeking a nearby collection location. A centre’s address, timings and available tests should be confirmed directly. The Navi Mumbai registered office is not a substitute for checking the actual collection point selected for a booking.

Healthcare and Institutional Diagnostic Support

Thyrocare’s published business scope includes doctors, hospitals, nursing homes, employers, insurers, health-technology platforms and government organisations. These relationships concern diagnostic testing and associated collection/logistics arrangements, rather than the purchase of one standard consumer package. An institutional enquiry should establish the requested test menu, locations, reporting arrangements and responsibilities in the proposed service scope. No universal contract terms or report-delivery commitment are stated here.

Specialty Allergy Testing

A company release dated 7 May 2026 describes expansion into advanced allergy testing using the Phadia platform. This adds a specific specialty-testing area beyond the familiar thyroid and wellness ranges. It is a dated company disclosure, not a guarantee that every assay is available at every collection point. Clinicians and patients should confirm the precise investigation, specimen and processing route with Thyrocare.

Workplace and Insurance Health Programmes

The FY2025–26 report describes annual employee check-ups, pre-employment screening, pre-policy medical evaluations and on-site diagnostic camps. These programmes require an agreed population, test scope and collection plan rather than one standard retail package.

Additional Home and Women’s Health Services

The same report describes ECG@Home and the Her Check women’s-health portfolio. ECG recording differs from blood-sample collection; the appropriate service and local availability should be established when enquiring.